Sonoma Pharmaceuticals (FRA:O8Z3) Change In Other Working Capital : €-0.01 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Sonoma Pharmaceuticals Change In Other Working Capital?

Sonoma Pharmaceuticals's Change In Other Working Capital for the quarter that ended in Dec. 2023 was €-0.02 Mil. It means Sonoma Pharmaceuticals's Other Working Capital declined by €0.02 Mil from Sep. 2023 to Dec. 2023 .

Sonoma Pharmaceuticals's Change In Other Working Capital for the fiscal year that ended in Mar. 2023 was €-1.20 Mil. It means Sonoma Pharmaceuticals's Other Working Capital declined by €1.20 Mil from Mar. 2022 to Mar. 2023 .

Sonoma Pharmaceuticals Change In Other Working Capital Historical Data

The historical data trend for Sonoma Pharmaceuticals's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoma Pharmaceuticals Change In Other Working Capital Chart

Sonoma Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Other Working Capital

Get a 7-Day Free Trial

-0.02

-0.73

-0.07

0.76

-1.20

Sonoma Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Other Working Capital	Get a 7-Day Free Trial															0.13	-0.19	0.04	0.17	-0.02

Sonoma Pharmaceuticals Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01 Mil.

Sonoma Pharmaceuticals Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Sonoma Pharmaceuticals's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sonoma Pharmaceuticals (FRA:O8Z3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sonoma Pharmaceuticals Inc (FRA:O8Z3) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

SNOA:USA O8Z3:Germany

Address

5445 Conestoga Court, Suite 150, Boulder, CO, USA, 80301

Website

https://www.sonomapharma.com

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.

Sonoma Pharmaceuticals (FRA:O8Z3) Headlines

No Headlines